P/E ratio for T2 Biosystems (TTOO)
P/E ratio as of May 2024 (TTM): -0.0197
According to T2 Biosystems 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0196584. At the end of 2022 the company had a P/E ratio of -0.0012.
P/E ratio history for T2 Biosystems from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0012 | -99.85% |
| 2021 | -0.8481 | -42.07% |
| 2020 | -1.46 | 186.57% |
| 2019 | -0.5109 | -62.49% |
| 2018 | -1.36 | 11.41% |
| 2017 | -1.22 | -1.45% |
| 2016 | -1.24 | -50.11% |
| 2015 | -2.49 | -40.51% |
| 2014 | -4.18 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Aldeyra Therapeutics
ALDX | -4.60 | 23,276.83% | 🇺🇸 USA |
 CareDx CDNA | -9.47 | 48,094.97% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.